Ruffer LLP

Position in EXEL — Exelixis, Inc.

CIK 1426859 London, X0

Position in EXEL

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,057,717

+$3,019,622 QoQ

Shares Held

117,923

+153.6% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Healthcare · as of Jun 30, 2026

Ruffer LLP holds $15,387,774 across 3 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	52,291	$5,927,707
2	JAZZ	Jazz Pharmaceuticals plc	24,567	$5,919,909
3	ADMA	Adma Biologics, Inc.	422,958	$3,540,158

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,057,717	117,923	+153.6%	Shares	Sole	2026-05-13
2025-12-31	$2,038,095	46,500	-43.1%	Shares	Sole	2026-01-28
2025-09-30	$3,374,044	81,696	+7.1%	Shares	Sole	2025-11-03
2025-06-30	$3,363,744	76,310	-36.5%	Shares	Sole	2025-07-16
2025-03-31	$4,437,931	120,204	+8.5%	Shares	Sole	2025-05-09
2024-12-31	$3,688,208	110,757	—	Shares	Sole	2025-02-07
No filing history on record for this holder in this stock.